Success Metrics

Clinical Success Rate
40.0%

Based on 2 completed trials

Completion Rate
40%(2/5)
Active Trials
2(25%)
Results Posted
50%(1 trials)
Terminated
3(38%)

Phase Distribution

Ph not_applicable
3
38%
Ph phase_1
2
25%
Ph phase_2
1
13%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
3(50.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

40.0%

2 of 5 finished

Non-Completion Rate

60.0%

3 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(2)
Terminated(3)

Detailed Status

Terminated3
Recruiting2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
40.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
N/A3 (50.0%)

Trials by Status

recruiting225%
terminated338%
not_yet_recruiting113%
completed225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8